AI-generated summary
The authors report a randomized, sham-controlled trial of morning bright light therapy added to medication in 95 adults with a current major depressive episode, bipolar or unipolar, without a seasonal pattern. The overall improvement in depression scores did not differ significantly from the sham group, but response and remission rates were higher with light therapy, and the authors describe these as significant.
- Participants
- 95
- Who or what was studied
- Adults aged 18 to 70 with a current major depressive episode in bipolar or unipolar disorder without a seasonal pattern, whose existing medication was insufficiently effective
- Limits stated in the abstract
- The primary depression score showed no significant difference, the sample was small with 12 dropouts, and the authors call for further studies to identify who may benefit most.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Depression, Sham, Bright light therapy, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.